The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Customized Peptide Synthesis Market Research Report 2025

Global Customized Peptide Synthesis Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1720303

No of Pages : 93

Synopsis
Custom peptide synthesis is the commercial production of peptides for use in biochemistry, biology, biotechnology, pharmacology and molecular medicine. Custom peptide synthesis provides synthetic peptides as valuable tools to biomedical laboratories.
The global Customized Peptide Synthesis market was valued at US$ 993 million in 2023 and is anticipated to reach US$ 1663.7 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.
This report aims to provide a comprehensive presentation of the global market for Customized Peptide Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Customized Peptide Synthesis.
Report Scope
The Customized Peptide Synthesis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Customized Peptide Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Customized Peptide Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
Segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Customized Peptide Synthesis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Customized Peptide Synthesis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CRO Peptides
1.2.3 CMO Peptides
1.2.4 Generic API Peptides
1.3 Market by Application
1.3.1 Global Customized Peptide Synthesis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Customized Peptide Synthesis Market Perspective (2019-2030)
2.2 Customized Peptide Synthesis Growth Trends by Region
2.2.1 Global Customized Peptide Synthesis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Customized Peptide Synthesis Historic Market Size by Region (2019-2024)
2.2.3 Customized Peptide Synthesis Forecasted Market Size by Region (2025-2030)
2.3 Customized Peptide Synthesis Market Dynamics
2.3.1 Customized Peptide Synthesis Industry Trends
2.3.2 Customized Peptide Synthesis Market Drivers
2.3.3 Customized Peptide Synthesis Market Challenges
2.3.4 Customized Peptide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Customized Peptide Synthesis Players by Revenue
3.1.1 Global Top Customized Peptide Synthesis Players by Revenue (2019-2024)
3.1.2 Global Customized Peptide Synthesis Revenue Market Share by Players (2019-2024)
3.2 Global Customized Peptide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Customized Peptide Synthesis Revenue
3.4 Global Customized Peptide Synthesis Market Concentration Ratio
3.4.1 Global Customized Peptide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Customized Peptide Synthesis Revenue in 2023
3.5 Customized Peptide Synthesis Key Players Head office and Area Served
3.6 Key Players Customized Peptide Synthesis Product Solution and Service
3.7 Date of Enter into Customized Peptide Synthesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Customized Peptide Synthesis Breakdown Data by Type
4.1 Global Customized Peptide Synthesis Historic Market Size by Type (2019-2024)
4.2 Global Customized Peptide Synthesis Forecasted Market Size by Type (2025-2030)
5 Customized Peptide Synthesis Breakdown Data by Application
5.1 Global Customized Peptide Synthesis Historic Market Size by Application (2019-2024)
5.2 Global Customized Peptide Synthesis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Customized Peptide Synthesis Market Size (2019-2030)
6.2 North America Customized Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Customized Peptide Synthesis Market Size by Country (2019-2024)
6.4 North America Customized Peptide Synthesis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Customized Peptide Synthesis Market Size (2019-2030)
7.2 Europe Customized Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Customized Peptide Synthesis Market Size by Country (2019-2024)
7.4 Europe Customized Peptide Synthesis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Customized Peptide Synthesis Market Size (2019-2030)
8.2 Asia-Pacific Customized Peptide Synthesis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Customized Peptide Synthesis Market Size by Region (2019-2024)
8.4 Asia-Pacific Customized Peptide Synthesis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Customized Peptide Synthesis Market Size (2019-2030)
9.2 Latin America Customized Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Customized Peptide Synthesis Market Size by Country (2019-2024)
9.4 Latin America Customized Peptide Synthesis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Customized Peptide Synthesis Market Size (2019-2030)
10.2 Middle East & Africa Customized Peptide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Customized Peptide Synthesis Market Size by Country (2019-2024)
10.4 Middle East & Africa Customized Peptide Synthesis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Detail
11.1.2 Bachem Business Overview
11.1.3 Bachem Customized Peptide Synthesis Introduction
11.1.4 Bachem Revenue in Customized Peptide Synthesis Business (2019-2024)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Detail
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Customized Peptide Synthesis Introduction
11.2.4 PolyPeptide Revenue in Customized Peptide Synthesis Business (2019-2024)
11.2.5 PolyPeptide Recent Development
11.3 GL Biochem
11.3.1 GL Biochem Company Detail
11.3.2 GL Biochem Business Overview
11.3.3 GL Biochem Customized Peptide Synthesis Introduction
11.3.4 GL Biochem Revenue in Customized Peptide Synthesis Business (2019-2024)
11.3.5 GL Biochem Recent Development
11.4 Xinbang
11.4.1 Xinbang Company Detail
11.4.2 Xinbang Business Overview
11.4.3 Xinbang Customized Peptide Synthesis Introduction
11.4.4 Xinbang Revenue in Customized Peptide Synthesis Business (2019-2024)
11.4.5 Xinbang Recent Development
11.5 Hybio
11.5.1 Hybio Company Detail
11.5.2 Hybio Business Overview
11.5.3 Hybio Customized Peptide Synthesis Introduction
11.5.4 Hybio Revenue in Customized Peptide Synthesis Business (2019-2024)
11.5.5 Hybio Recent Development
11.6 USVPeptides
11.6.1 USVPeptides Company Detail
11.6.2 USVPeptides Business Overview
11.6.3 USVPeptides Customized Peptide Synthesis Introduction
11.6.4 USVPeptides Revenue in Customized Peptide Synthesis Business (2019-2024)
11.6.5 USVPeptides Recent Development
11.7 Thermofischer
11.7.1 Thermofischer Company Detail
11.7.2 Thermofischer Business Overview
11.7.3 Thermofischer Customized Peptide Synthesis Introduction
11.7.4 Thermofischer Revenue in Customized Peptide Synthesis Business (2019-2024)
11.7.5 Thermofischer Recent Development
11.8 ScinoPharm
11.8.1 ScinoPharm Company Detail
11.8.2 ScinoPharm Business Overview
11.8.3 ScinoPharm Customized Peptide Synthesis Introduction
11.8.4 ScinoPharm Revenue in Customized Peptide Synthesis Business (2019-2024)
11.8.5 ScinoPharm Recent Development
11.9 Genscript
11.9.1 Genscript Company Detail
11.9.2 Genscript Business Overview
11.9.3 Genscript Customized Peptide Synthesis Introduction
11.9.4 Genscript Revenue in Customized Peptide Synthesis Business (2019-2024)
11.9.5 Genscript Recent Development
11.10 AnaSpec
11.10.1 AnaSpec Company Detail
11.10.2 AnaSpec Business Overview
11.10.3 AnaSpec Customized Peptide Synthesis Introduction
11.10.4 AnaSpec Revenue in Customized Peptide Synthesis Business (2019-2024)
11.10.5 AnaSpec Recent Development
11.11 New England Peptide
11.11.1 New England Peptide Company Detail
11.11.2 New England Peptide Business Overview
11.11.3 New England Peptide Customized Peptide Synthesis Introduction
11.11.4 New England Peptide Revenue in Customized Peptide Synthesis Business (2019-2024)
11.11.5 New England Peptide Recent Development
11.12 CPC Scientific
11.12.1 CPC Scientific Company Detail
11.12.2 CPC Scientific Business Overview
11.12.3 CPC Scientific Customized Peptide Synthesis Introduction
11.12.4 CPC Scientific Revenue in Customized Peptide Synthesis Business (2019-2024)
11.12.5 CPC Scientific Recent Development
11.13 JPT
11.13.1 JPT Company Detail
11.13.2 JPT Business Overview
11.13.3 JPT Customized Peptide Synthesis Introduction
11.13.4 JPT Revenue in Customized Peptide Synthesis Business (2019-2024)
11.13.5 JPT Recent Development
11.14 21st Century Bio
11.14.1 21st Century Bio Company Detail
11.14.2 21st Century Bio Business Overview
11.14.3 21st Century Bio Customized Peptide Synthesis Introduction
11.14.4 21st Century Bio Revenue in Customized Peptide Synthesis Business (2019-2024)
11.14.5 21st Century Bio Recent Development
11.15 LifeTein
11.15.1 LifeTein Company Detail
11.15.2 LifeTein Business Overview
11.15.3 LifeTein Customized Peptide Synthesis Introduction
11.15.4 LifeTein Revenue in Customized Peptide Synthesis Business (2019-2024)
11.15.5 LifeTein Recent Development
11.16 Proimmune
11.16.1 Proimmune Company Detail
11.16.2 Proimmune Business Overview
11.16.3 Proimmune Customized Peptide Synthesis Introduction
11.16.4 Proimmune Revenue in Customized Peptide Synthesis Business (2019-2024)
11.16.5 Proimmune Recent Development
11.17 Biomatik
11.17.1 Biomatik Company Detail
11.17.2 Biomatik Business Overview
11.17.3 Biomatik Customized Peptide Synthesis Introduction
11.17.4 Biomatik Revenue in Customized Peptide Synthesis Business (2019-2024)
11.17.5 Biomatik Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’